Maura Kelly Hagan MD FACP

Hematologic Oncology

Physician

7501 Right Flank RdSuite 600Mechanicsville, VA 23116
Phone+1 804-559-2489
Fax+1 804-730-5847

Dr. Hagan is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Hagan's full profile Already have an account?

Summary

Dr. Maura Hagan is a hematologist oncologist based in Mechanicsville, VA. She completed her fellowship in Hematology and Medical Oncology at Emory University School of Medicine and her residency in Internal Medicine at Allegheny Health Network Medical Education Consortium. Dr. Hagan is experienced in a variety of cancers (including breast, lung and colon), platelet disorders, infection-induced thrombocytopenia, myeloproliferative disorders and anemia. She has contributed to research with publications on metastatic breast cancer treatments with notable citations. Dr. Hagan has received certifications for CMS Meaningful Use Stages 1 and 2 in Oncology from ARIA oncology information system and OncoEMR by Flatiron Health. Outside of work, she loves to make jewelry with her husband, a lampwork bead artist. They own a used bookstore and local arts gallery in Mechanicsville, supporting local authors and artisans.

Education & Training

Emory University School of MedicineFellowship, Hematology and Medical Oncology, 1989 - 1992
Allegheny Health Network Medical Education Consortium (AGH)Residency, Internal Medicine, 1986 - 1989
Eastern Virginia Medical SchoolClass of 1986

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

VA State Medical License 1992 - 2028
GA State Medical License 1989 - 1993
PA State Medical License 1987 - 1992
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification ARIA oncology information system (for Medical Oncology), Varian Medical Systems, 2014-2015, 2017
CMS Meaningful Use Stage 2 Certification OncoEMR by Flatiron Health, Flatiron Health, Inc., 2014-2015, 2017

Publications & Presentations

PubMed

15 citations
An Open-Label Safety Study of Lapatinib Plus Trastuzumab Plus Paclitaxel in First-Line HER2-Positive Metastatic Breast Cancer
Francisco J. Esteva, Sandra X. Franco, Maura K. Hagan, Abenaa M. Brewster, Robert A. Somer
The Oncologist. 2013-06-01
32 citations
Phase II study evaluating lapatinib in combination with nab-paclitaxel in HER2-overexpressing metastatic breast cancer patients who have received no more than one prio...
Denise A. Yardley, Lowell L. Hart, Linda D. Bosserman, Mansoor N. Salleh, David M. Waterhouse
Breast Cancer Research and Treatment. 2013-01-01